BWXT in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with BWXT today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Government nuclear components and fuel account for most of BWX Technologies’ revenue. It designs and manufactures reactor components and fuel for U.S. Navy submarines and aircraft carriers, and also processes nuclear materials and operates and cleans up government nuclear sites. The U.S. Government is its largest customer, paying directly or through prime contractors under fixed-price contracts or arrangements that reimburse allowable costs plus a fee. This business depends on federal nuclear-program spending and continuing Congressional funding approvals.
Its commercial business supplies nuclear utilities with equipment, fuel, engineering and maintenance services to keep plants operating and extend their lives. It also sells medical radioisotopes and radiopharmaceuticals to nuclear-medicine and life-sciences customers. Commercial demand depends on nuclear-power investment, the timing of plant maintenance and refurbishment—particularly in Canada—and demand for nuclear-medicine products.
The company needs licenses to possess and process nuclear materials and operate its nuclear facilities, with continuing oversight by U.S. and Canadian regulators. Classified government work also requires appropriately cleared personnel, while its medical-isotope business is subject to U.S. and Canadian health-agency oversight.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
BWXT’s results depend mainly on U.S. naval nuclear spending, while Westinghouse and Framatome—neither shown here—compete with its commercial nuclear business.
Huntington Ingalls builds and refuels nuclear-powered ships for the U.S. Navy that need BWXT’s reactor components and fuel, so its carrier and submarine work points to demand for BWXT. It also competes with BWXT for government nuclear-site services contracts.
Curtiss-Wright shares BWXT’s exposure to naval and commercial nuclear customers: it supplies naval propulsion equipment and commercial nuclear technologies, while BWXT supplies reactor components and fuel to those markets.
Cameco competes with BWXT to sell fuel bundles and reactor components for CANDU reactors to nuclear utilities. Its fuel-manufacturing business is the part to watch for this overlap, rather than its uranium mining business.
Mirion Technologies, Inc. serves the same nuclear-facility and medical markets as BWXT, selling radiation-monitoring and nuclear-medicine equipment where BWXT sells components, services and isotopes. Mirion’s replacement and service revenue from equipment already in nuclear plants offers a view of spending at operating plants, relevant to BWXT’s maintenance and plant-life-extension work.
Centrus Energy and BWXT serve different steps in nuclear fuel supply: Centrus enriches uranium and provides government nuclear technical services, while BWXT makes fuel and processes uranium for government and utility customers. Centrus’s sales of low-enriched uranium to nuclear utilities offer a view of the fuel demand they share.
Mirion Technologies, Inc. earningsMIR
Mirion Technologies’ report will show whether operating nuclear plants are spending on equipment replacements and services, activity that also underpins BWX Technologies’ maintenance and plant-life-extension work.
Look for growth in Mirion’s equipment-replacement and service sales, alongside the performance of its nuclear-plant business. Strength in both would point to firmer spending at operating plants, supporting the demand backdrop for BWX Technologies’ maintenance and life-extension work; weakness would mean less support from this channel, not proof of BWX’s own results.
Huntington Ingalls Industries, Inc. earningsHII
Huntington Ingalls Industries’ report will show how its U.S. Navy shipbuilding and refueling work is progressing, programs that need BWX Technologies’ reactor components and fuel.
Read Huntington Ingalls Industries’ shipbuilding and refueling progress alongside revenue or backlog in those activities. Steady execution and orders would support demand for BWX Technologies’ components and fuel; delays or weakening orders would put that demand path under pressure, but HII’s figures do not establish that BWXT has won or recognized the work.
Cameco Corporation earningsCCJ
Cameco’s report will show how its CANDU fuel-manufacturing business is doing; it and BWX Technologies both sell fuel bundles and reactor components to nuclear utilities.
Focus on sales and profit in Cameco’s fuel-manufacturing business, distinguishing volume growth from changes in price or product mix. Sales and profit rising together would indicate stronger utility demand but also a more capable rival for overlapping BWX Technologies work; weaker sales that reflect lost competitiveness could ease pressure, while broad utility-demand weakness could hurt BWXT too.
BWX Technologies, Inc. earningsThis company
BWX Technologies’ report will show how much of its government-contract and commercial nuclear revenue growth is turning into profit.
Compare revenue with operating margin—the share of revenue left as operating profit—in Government Operations and Commercial Operations. Revenue rising while margins hold or improve would show that contract execution and commercial demand are translating into profit; revenue rising while margins fall would show costs or the mix of work eating into that growth.